CMS to make some pandemic telehealth provisions permanent
Editor's Note The Centers for Medicare & Medicaid Services (CMS) administrator Seema Verma says use of telehealth has grown dramatically during the COVID-19 pandemic, and some provisions that were extended temporarily will be made permanent, the June 2 Becker’s Hospital Review reports. During the pandemic, CMS expanded access to telehealth…
CMS unveils enhanced enforcement actions for nursing homes based on COVID-19 data, inspections
Editor's Note The Centers for Medicare & Medicaid Services (CMS) on June 1 unveiled enhanced enforcement actions for nursing homes with violations of infection control practices. The enhanced and targeted accountability actions are based on trends in recent data regarding the incidence of COVID-19 in nursing homes and infection control…
Joint Commission to resume some surveys, review activities
Editor's Note The Joint Commission on May 27 announced that it will begin to resume some survey and review activities in June, and account executives will be contacting organizations due for a survey. The Joint Commission is reviewing a variety of factors and criteria to help determine where and which…
CDC releases reopening guidelines
Editor's Note The Centers for Disease Control and Prevention (CDC) on May 20 posted two new resources to help states reopen. The first is a 60-page document that includes information on general and healthcare surveillance and continuing guidance on infection control, contact tracing, and testing. It also includes a standardized…
AORN, AHA, AdvaMed issue release re-entry guidance
Editor's Note: The Association of periOperative Registered Nurses (AORN), American Hospital Association (AHA), and Advanced Medical Technology Association (AdvaMed) on May 19 released a “Re-entry Guidance for Health Care Facilities and Medical Device Representatives.” The guidance, which builds on the April 17 joint statement by AORN, AHA, American College of…
NIH begins clinical trial of hydroxychloroquine, azithromycin for COVID-19 treatment
Editor's Note The National Institutes of Health (NIH) on May 14 announced that it is enrolling adults with mild to moderate COVID-19 in a study of treatment with hydroxychloroquine and azithromycin. The Phase 2b trial is enrolling around 2,000 adults across the US. Participants must have confirmed infection with SARS-CoV-2…
CDC posts updated point-of-care testing guidelines for COVID-19
Editor's Note The Centers for Disease Control and Prevention on May 12 posted updated point-of-care (POC) testing biosafety guidelines for COVID-19. The update includes guidance for: use of instruments in a location associated with a current Clinical Laboratory Improvement Amendments certificate site- and activity-specific risk assessment proper staff training adherence…
California pharmacists to begin testing patients for COVID-19
Editor's Note On May 12, California's Governor Gavin Newsom announced that California pharmacists will be allowed to collect specimens and order COVID-19 tests. Specimens will be are processed at public health, university, or commercial labs. The move is an effort to increase the state’s testing capacity as it modifies its…
FDA accelerates development of COVID-19 prevention, treatment options
Editor's Note The Food & Drug Administration on May 11 took new actions to accelerate the development of novel prevention and treatment options for COVID-19. The agency is providing guidance documents to make the process for submitting applications to initiate studies for new drugs and biological products more efficient. The…
CMS releases proposed inpatient payment rule for FY 2021
Editor's Note The Centers for Medicare & Medicaid Services (CMS) on May 11 released a proposed rule that increases Medicare inpatient prospective payment system (IPPS) rates by a net of 3.1% in FY 2021, compared to 2020, for acute care hospitals participating in the Hospital Inpatient Quality Reporting Program that…
